| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.094 | 0.003 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |